Stay updated with breaking news from Nasdaq ispc. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
ISpecimen Inc. (NASDAQ:ISPC – Get Free Report) insider Benjamin Bielak bought 18,000 shares of iSpecimen stock in a transaction that occurred on Thursday, September 14th. The stock was purchased at an average cost of $0.72 per share, with a total value of $12,960.00. Following the completion of the transaction, the insider now owns 84,348 shares […] ....
Company to Focus on Core Revenue Drivers, New Revenue Growth Opportunities from Recently Launched Sequencing Procurement Program and Expense Reductions. ....
ISpecimen Inc. (NASDAQ:ISPC – Get Rating) saw a significant growth in short interest in April. As of April 30th, there was short interest totalling 49,300 shares, a growth of 14.1% from the April 15th total of 43,200 shares. Currently, 0.9% of the company’s stock are sold short. Based on an average trading volume of 28,300 […] ....
ISpecimen (NASDAQ:ISPC – Get Rating) is one of 41 publicly-traded companies in the “Commercial physical research” industry, but how does it contrast to its competitors? We will compare iSpecimen to related businesses based on the strength of its dividends, risk, institutional ownership, earnings, analyst recommendations, profitability and valuation. Valuation and Earnings This table compares iSpecimen […] ....